Breast Cancer Risks Linked to Environmental Factors and Hormonal Contraceptives
Breast cancer diagnoses are rising, with certain exposures, such as hormonal contraception, potentially influencing risk, according to reports from Le Dauphiné Libéré and leFaso.net. Public health discussions, particularly during awareness campaigns like Octobre rose, increasingly focus on how external pollutants and medical treatments influence mammary health. Prevention also relies on understanding environmental factors that can affect health and adopting wellness-promoting behaviors, as noted by Armelle Ouédraogo.
Hormonal Contraceptives and Endocrine Disrupters
Current or recent use of hormonal contraception is associated with an estimated 20% to 30% increase in the relative risk of developing breast cancer, as detailed by leFaso.net. This association has been observed with combined hormonal contraceptives and specific progestogen methods, though the risk level can vary depending on the method used, the duration of exposure, and individual characteristics. Dr. Certain studies suggest that exposure to hormones produced naturally by the body, known as endogenous hormones, or brought from the outside, known as exogenous hormones, could influence the risk of developing breast cancer. These exogenous hormones, alongside natural estrogen and progesterone, can stimulate the multiplication of specific mammary cells.
Environmental Pollutants Under Scientific Investigation
Environmental toxins play a significant role in altering hormonal functions, according to Le Dauphiné Libéré. Available human data vary according to the studied substances, exposure periods, and methods used, while several endocrine disrupters are researched for their potential effects on mammary health and their possible involvement in the onset of breast cancer. Researchers are closely monitoring specific polychlorinated biphenyls, notably PCB-99, PCB-105, PCB-118, PCB-138, and PCB-183, due to associations with breast cancer risk. Furthermore, perfluoroalkyl and polyfluoroalkyl substances, commonly known as PFAS, constitute a broad family of chemical substances used in various industrial and consumer products, and are under evaluation for their disruptive effects on the endocrine system and their connection to various malignancies, including breast cancer.
Criticism of Awareness Campaigns and Individual Focus
Amélie Cadier-Loriaud argues that traditional awareness campaigns such as Octobre rose frequently overshadow environmental causes of breast cancer, framing the disease primarily around individual lifestyle choices rather than external pollutants, Le Monde reported. This perspective shifts the responsibility of prevention from public safety regulations governing chemicals in everyday consumer products—such as PVC flooring and plastics—toward personal behavior.
